The 5-HT7 receptor antagonist SB-656104A fails to affect breakpoints for cocaine self-administration in male rats

Behavioural Pharmacology · Published 2026-04-10 · DOI 10.1097/fbp.0000000000000877

Authors being retrieved — see the publisher record. https://doi.org/10.1097/fbp.0000000000000877

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Parsing the hypophagic and anxiogenic effects of cocaine in male and female rats · Behavioural Pharmacology · 2025 · Same journal
• Investigation of p-coumaric acid on intracerebroventricular lipopolysaccharide-induced spatial memory impairment and neuroinflammation in rats · Behavioural Pharmacology · 2025 · Same journal
• Comparison of the hot-plate pain effect between three inhalation methods and subcutaneous injection of heroin · Behavioural Pharmacology · 2025 · Same journal
• Delta opioid receptors on parvalbumin cells are necessary for the convulsant and anxiolytic effects of the delta agonist SNC80 · Behavioural Pharmacology · 2026 · Same journal
• Sex-dependent analgesic effects of phoenixin-14 on mechanical allodynia in mouse models of neuropathic and inflammatory pain · Behavioural Pharmacology · 2026 · Same journal
• Limited effects of zolmitriptan maintenance on the pharmacodynamic profile of intravenous cocaine in humans · Behavioural Pharmacology · 2025 · Same journal
• N-acetylcysteine: a promising strategy for alleviating damages induced by maternal deprivation in neonatal rats · Behavioural Pharmacology · 2026 · Same journal
• A review on the validity of animal models for neuropsychiatric disorders: an exploration of anhedonia · Behavioural Pharmacology · 2025 · Same journal
• Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms · Behavioural Pharmacology · 2026 · Same journal
• Wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, suppresses methamphetamine-induced stereotypy and hyperlocomotion in mice · Behavioural Pharmacology · 2026 · Same journal